Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea
| Autor: | Yongyoth Herabutya, Sangchai Preutthipan |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Hysterectomy business.industry medicine.medical_treatment media_common.quotation_subject Pelvic pain Obstetrics and Gynecology Ablation medicine.disease Surgery Hypomenorrhea medicine Endometrial ablation Amenorrhea Adenomyosis medicine.symptom business Menstrual cycle media_common |
| Zdroj: | Journal of Obstetrics and Gynaecology Research. 36:1031-1036 |
| ISSN: | 1341-8076 |
| DOI: | 10.1111/j.1447-0756.2010.01251.x |
| Popis: | Aim: The aim of this study was to assess the long-term effectiveness and safety of hysteroscopic rollerball endometrial ablation as a surgical management of adenomyosis with menorrhagia and/or dysmenorrhea. We compared the results of patients who underwent pretreatment with gonadotropin-releasing hormone (GnRH) agonist with the results of those who did not. Methods: A retrospective study included 190 adenomyotic patients who suffered from menorrhagia and/or dysmenorrhea and underwent hysteroscopic rollerball endometrial ablation. Main outcome measures were rates of successful operation, complications, improvement of abnormal uterine bleeding and pelvic pain after the surgery. Results: The majority of the patients (142, 74.7%) underwent hysteroscopic rollerball endometrial ablation during the early proliferative phase of the menstrual cycle. The rest were operated on after GnRH agonist pretreatment for 6–8 weeks. Ablations were successfully performed on all patients in a day surgery setting. The average operation time was 36.3 ± 7.1 min. The mean glycine deficit was 583.4 ± 247.3 mL. The ablation in the no-pretreatment group took a significantly longer time and had more glycine absorption compared to the GnRH agonist pretreatment group (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text